Back

Risk of bleeding in patients with atrial fibrillation: ARC-HBR outperforms HASBLED

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in arrhythmias and device therapy 1 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Filipa Gerardo

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

7 More presentations in this session

Presentation thumbnail
Pulmonary veins anatomy variants and cryoballoon ablation for atrial fibrillation
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Are time and temperature profile of catheter cryoablation predictors of successful pulmonary vein isolation?
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of P wave morphology in post-electrical cardioversion atrial fibrillation patients
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Cardioneuroablation experience for the treatment of vagally-mediated bradyarrhythmias
Doctor S. Paula (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Heart failure prognosis in obese and overweight in-patients in a third level cardiovascular center in Mexico: 1 year follow up
Doctor R. Gonzalez Mayo (Ciudad De Mexico, MX)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in arrhythmias and device therapy 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Risk stratification using the academic research consortium high bleeding risk criteria in patients with atrial fibrillation undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation
thumbnail
Congress Presentation
The usefulness of the direct oral anticoagulant score for predicting bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: a multicenter study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources